Tissue Plasminogen Activator for Acute Ischemic Stroke.¶
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue Plasminogen Activator for Acute Ischemic Stroke. New England Journal of Medicine, 333(24), 1581-1587.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Kairos
- Medicine and clinical intervention. Therapeutic windows in stroke care, sepsis resuscitation, staging-dependent treatment, and circadian drug dosing — same intervention, different state, different outcome.
This sourceEstablishes the time-limited therapeutic window: thrombolysis within three hours of onset improves outcome despite hemorrhage risk — the canonical state-gated clinical window (also anchoring the broader therapeutic-window claim).
- Medicine and clinical intervention. Therapeutic windows in stroke care, sepsis resuscitation, staging-dependent treatment, and circadian drug dosing — same intervention, different state, different outcome.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:e50ad8fc683f · see in the full table